文献速递慢性肾脏病

一氧化氮前体与二甲基精氨酸作为一般人群加速测定的GFR下降风险标志物

Nitric Oxide Precursors and Dimethylarginines as Risk Markers for Accelerated Measured GFR Decline in the General Population.
PubMed 文献 · Kidney Int Rep · 2023-01-19

在1407名健康中年欧洲裔参与者的前瞻性队列中,中位随访11年期间重复测定碘海醇清除率。较高的瓜氨酸和鸟氨酸水平与加速GFR下降相关,较高的瓜氨酸与CKD新发相关,而较高的SDMA与较慢的年度GFR下降相关。

要点

  • 较高的瓜氨酸与加速GFR下降相关(OR 1.43,95%CI 1.16-1.76,每SD升高)。
  • 较高的鸟氨酸与加速GFR下降相关(OR 1.23,95%CI 1.01-1.49,每SD升高)。
  • 较高的瓜氨酸与CKD新发相关(HR 1.33,95%CI 1.07-1.66,每SD升高)。

核心结论

  • NO前体与结局之间的关联提示,NO代谢在中年人群年龄相关GFR下降和CKD发生的发病机制中起重要作用。

研究设计与样本

  • 前瞻性队列研究,纳入1407名健康中年欧洲裔参与者,来自肾脏碘海醇清除率调查(RENIS)。
  • 在中位随访11年期间重复使用碘海醇清除率测定GFR。

主要发现

  • 较高的SDMA与较慢的年度GFR下降相关。
  • 较高的瓜氨酸与加速GFR下降相关(OR 1.43,95%CI 1.16-1.76,每SD升高)。
  • 较高的鸟氨酸与加速GFR下降相关(OR 1.23,95%CI 1.01-1.49,每SD升高)。
  • 较高的瓜氨酸与CKD新发相关(HR 1.33,95%CI 1.07-1.66,每SD升高)。

关键数值与推荐

  • 加速GFR下降定义为GFR下降最快的10%。
  • CKD新发定义为GFR < 60 ml/min per 1.73 m2。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Nitric oxide (NO) deficiency is associated with endothelial dysfunction, hypertension, atherosclerosis, and chronic kidney disease (CKD). Reduced NO bioavailability is hypothesized to play a vital role in kidney function impairment and CKD. We investigated the association of serum levels of endogenous inhibitors of NO, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), and precursors of NO, arginine, citrulline, and ornithine, with a decline in glomerular filtration rate (GFR) and new-onset CKD. METHODS: In a prospective cohort study of 1407 healthy, middle-aged participants of Northern European origin in the Renal Iohexol Clearance Survey (RENIS), GFR was measured repeatedly with iohexol clearance during a median follow-up time of 11 years. GFR decline rates were analyzed using a linear mixed model, new-onset CKD (GFR < 60 ml/min per 1.73 m2) was analyzed with interval-censored Cox regression, and accelerated GFR decline (the 10% with the steepest GFR decline) was analyzed with logistic regression. RESULTS: Higher SDMA was associated with slower annual GFR decline. Higher levels of citrulline and ornithine were associated with accelerated GFR decline (odds ratio [OR], 1.43; 95% confidence interval [CI] 1.16-1.76 per SD higher citrulline and OR 1.23; 95% CI 1.01 to 1.49 per SD higher ornithine). Higher citrulline was associated with new-onset CKD, with a hazard ratio of 1.33 (95% CI 1.07-1.66) per SD higher citrulline. CONCLUSIONS: Associations between NO precursors and the outcomes suggest that NO metabolism plays a significant role in the pathogenesis of age-related GFR decline and the development of CKD in middle-aged people.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Rinde NB, Enoksen IT, Melsom T, et al. Nitric Oxide Precursors and Dimethylarginines as Risk Markers for Accelerated Measured GFR Decline in the General Population. Kidney Int Rep. 2023. PMID: 37069987. doi:10.1016/j.ekir.2023.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。